Tag: Interventional Oncology

Medtronic Expands Focus on Interventional Oncology with Its U.S. Launch of OptiSphere(TM) Embolization Spheres

DUBLIN – April 17, 2018 – Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular tumors. OptiSphere offers patients an alternative treatment option, a resorbable embolic, with comparable results to a permanent embolic.1 Hypervascular tumors can present as […]

Surefire Medical Presents Registry Data for Treatment of Liver Cancer at the 2018 SIR Annual Meeting

LOS ANGELES–(BUSINESS WIRE)–Surefire Medical, Inc. (Surefire), an oncology drug delivery company, announced today the presentation of data analyzing the efficacy and safety from its national patient registry. The data were presented as part of the 2018 Society for Interventional Radiology (SIR) Annual Meeting in Los Angeles, CA from March 17-22, 2018. […]